E.M. Biggart

414 total citations
8 papers, 289 citations indexed

About

E.M. Biggart is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Biomedical Engineering. According to data from OpenAlex, E.M. Biggart has authored 8 papers receiving a total of 289 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Endocrinology, Diabetes and Metabolism and 2 papers in Biomedical Engineering. Recurrent topics in E.M. Biggart's work include Advanced Biosensing Techniques and Applications (3 papers), Thyroid Disorders and Treatments (3 papers) and Advanced biosensing and bioanalysis techniques (2 papers). E.M. Biggart is often cited by papers focused on Advanced Biosensing Techniques and Applications (3 papers), Thyroid Disorders and Treatments (3 papers) and Advanced biosensing and bioanalysis techniques (2 papers). E.M. Biggart collaborates with scholars based in United Kingdom and India. E.M. Biggart's co-authors include Roger Ekins, Frederick Chu, F. W. Chu, D S O’Reilly, J. Shepherd, J.J. Series, C.J. Packard, Richard Chapman, G. H. Beastall and Andrew D. Paterson and has published in prestigious journals such as Analytica Chimica Acta, Clinica Chimica Acta and Journal of Immunological Methods.

In The Last Decade

E.M. Biggart

8 papers receiving 264 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E.M. Biggart United Kingdom 7 174 86 79 64 17 8 289
T A Wilkins United Kingdom 9 40 0.2× 15 0.2× 87 1.1× 28 0.4× 42 2.5× 15 172
Yoichi Yoshida Japan 10 125 0.7× 11 0.1× 64 0.8× 16 0.3× 13 0.8× 46 332
R. K. Brown United States 7 66 0.4× 25 0.3× 25 0.3× 11 0.2× 14 0.8× 9 187
G E Valkirs United States 7 259 1.5× 21 0.2× 7 0.1× 47 0.7× 29 1.7× 9 394
John Walsby-Tickle United Kingdom 8 151 0.9× 21 0.2× 17 0.2× 38 0.6× 41 2.4× 14 298
E. I. Chazov Russia 9 74 0.4× 65 0.8× 6 0.1× 18 0.3× 11 0.6× 22 349
Giuseppe Ferrandino United States 11 198 1.1× 39 0.5× 260 3.3× 131 2.0× 50 2.9× 12 553
Rohn Millican United States 6 241 1.4× 72 0.8× 207 2.6× 13 0.2× 7 0.4× 6 399
Ilse A. E. Bollen Netherlands 13 237 1.4× 30 0.3× 10 0.1× 18 0.3× 6 0.4× 14 582
Paul Begovatz Germany 8 69 0.4× 89 1.0× 111 1.4× 8 0.1× 33 1.9× 11 406

Countries citing papers authored by E.M. Biggart

Since Specialization
Citations

This map shows the geographic impact of E.M. Biggart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E.M. Biggart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E.M. Biggart more than expected).

Fields of papers citing papers by E.M. Biggart

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E.M. Biggart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E.M. Biggart. The network helps show where E.M. Biggart may publish in the future.

Co-authorship network of co-authors of E.M. Biggart

This figure shows the co-authorship network connecting the top 25 collaborators of E.M. Biggart. A scholar is included among the top collaborators of E.M. Biggart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E.M. Biggart. E.M. Biggart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Logue, F.C., Ben D. Perry, E.M. Biggart, Richard Chapman, & G. H. Beastall. (1991). Production and characterisation of monoclonal antibodies to parathyroid hormone (1–34). Journal of Immunological Methods. 137(2). 159–166. 3 indexed citations
2.
Ekins, Roger, Frederick Chu, & E.M. Biggart. (1990). Fluorescence spectroscopy and its application to a new generation of high sensitivity, multi-microspot, multianalyte, immunoassay. Clinica Chimica Acta. 194(1). 91–114. 38 indexed citations
3.
Ekins, Roger, F. W. Chu, & E.M. Biggart. (1990). Multispot, multianalyte, immunoassay.. PubMed. 48(9). 655–66. 77 indexed citations
4.
Ekins, Roger, Frederick Chu, & E.M. Biggart. (1989). Development of microspot multi-analyte ratiometric immunoassay using dual fluorescent-labelled antibodies. Analytica Chimica Acta. 227. 73–96. 61 indexed citations
5.
Series, J.J., E.M. Biggart, D S O’Reilly, C.J. Packard, & J. Shepherd. (1988). Thyroid dysfunction and hypercholesterolaemia in the general population of Glasgow, Scotland. Clinica Chimica Acta. 172(2-3). 217–221. 48 indexed citations
6.
Biggart, E.M., et al.. (1987). Performance of the two-site immunoradiometric assay for serum thyroid-stimulating hormone. Journal of Immunological Methods. 104(1-2). 87–92. 8 indexed citations
7.
Fraser, William D., E.M. Biggart, D S O’Reilly, et al.. (1986). Are biochemical tests of thyroid function of any value in monitoring patients receiving thyroxine replacement?. BMJ. 293(6550). 808–810. 31 indexed citations
8.
Paterson, Andrew D., E.M. Biggart, Richard Chapman, & G. H. Beastall. (1985). Evaluation of a Time-Resolved Immunofluorometric Assay for Serum Thyroid Stimulating Hormone. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 22(6). 606–611. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026